Document Detail

Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats.
MedLine Citation:
PMID:  9875758     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Nonischemic myocardial dysfunction in patients with diabetes mellitus appears to be attenuated with long-term L-carnitine therapy. The effect of acute L-carnitine supplementation on rat hearts from euglycemic and diabetic animals subjected to ischemia and reperfusion is investigated in this study. METHODS: Study rats had diabetes mellitus induced by streptozocin (65 mg/kg intraperitoneally), and control rats had injection of saline solution (n = 12 per group). About 1 month later, the hearts were suspended on a Langendorff apparatus and perfused with either standard buffered Krebs-Henseleit solution or this standard solution supplemented with L-carnitine (5 mmol/L). After stabilization, normothermic, zero-flow ischemia was instituted for 20 minutes followed by 60 minutes of reperfusion. There were four study groups (n = 6 per group): hearts that were from euglycemic rats and that were perfused with standard buffered Krebs-Henseleit solution (E-STD); hearts that were from diabetic animals and that were perfused with the same standard buffered solution (DM-STD); hearts taken from diabetic animals and perfused with L-carnitine-enriched solution (DM-CAR); and hearts taken from euglycemic rats and perfused with the enriched solution (E-CAR). RESULTS: At 60 minutes of reperfusion, left ventricular developed pressure was significantly better in hearts from both groups (diabetic and euglycemic) with carnitine supplementation (DM-CAR versus DM-STD and E-CAR versus E-STD, p < 0.01 for both, by analysis of variance). Left ventricular end-diastolic pressure was significantly lower in the DM-CAR group compared with all other groups (p < 0.01 by analysis of variance). CONCLUSIONS: These findings suggest that acute L-carnitine supplementation significantly improves the recovery of the ischemic myocardium in diabetic and euglycemic rats.
V A Keller; B Toporoff; R M Raziano; J D Pigott; N L Mills
Related Documents :
7769458 - Effect of nicotinic acid on exogenous myocardial glucose utilization.
3732168 - Different types of postinsulin receptor defects contribute to insulin resistance in hea...
16598538 - Effect of an exercise training program on endothelial dysfunction in diabetic and non-d...
8750778 - Improvement of myocardial function and metabolism in diabetic rats by the carnitine pal...
14651328 - Evaluation of human resistin assays with serum from patients with type 2 diabetes and d...
7489198 - Hazard analyses of airborne contamination in clean rooms--application of a method for l...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  66     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-02-03     Completed Date:  1999-02-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1600-3     Citation Subset:  AIM; IM    
Department of Surgery, Tulane University Medical Center, New Orleans, Louisiana, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis
Carnitine / pharmacology,  therapeutic use*
Diabetes Mellitus, Experimental / complications,  drug therapy*
Heart / drug effects*
Myocardial Ischemia / drug therapy*,  physiopathology
Rats, Sprague-Dawley
Ventricular Function, Left / drug effects
Reg. No./Substance:
0/Blood Glucose; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Disadvantages of local repair in acute type A aortic dissection.
Next Document:  Repair of ruptured sinus of valsalva aneurysm: determinants of long-term survival.